Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias

Details for Australian Patent Application No. 2003230810 (hide)

International Classifications

Event Publications

14 August 2003 Complete Application Filed

Priority application(s): 60/422,589 30.10.02 US; 60/370,150 04.04.02 US; 60/408,292 05.09.02 US

4 December 2003 Application Open to Public Inspection

Published as AU-B-2003230810

26 February 2009 Application Accepted

Published as AU-B-2003230810

25 June 2009 Standard Patent Sealed

15 October 2009 Amendment Made

The nature of the amendment is: Amend the patentee name from CV Therapeutics, Inc. to Gilead Palo Alto, Inc.

2 February 2012 Assignment Registered

Gilead Palo Alto, Inc. The patent has been assigned to Gilead Sciences Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.